Cirevetmab, CAS 2473240-98-9

Product Description: Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021.

CAS Number: 2473240-98-9

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: H2O

Target: TGF-beta/Smad

• Artikelnummer: MEXHY-P99606-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99606-5
• Verpackungseinheit: 5mg
• Mengeneinheit: STK
• Konjugat: Unconjugated